KBC Group’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

KBC Group’s Portfolio HPTX Stock Details HPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3,254	Closed	-$149K	–	1451
2015 Q1	$149K	Sell	3,254 -526	-14%	-$15.7K	﹤0.01%	1174
2014 Q4	$91K	Buy	+3,780	New	+$85.2K	﹤0.01%	1326
2014 Q1	–	Sell	-6,344	Closed	-$129K	–	1384
2013 Q4	$129K	Buy	6,344 +2,821	+80%	+$66.4K	﹤0.01%	1098
2013 Q3	$92K	Buy	+3,523	New	+$88.2K	﹤0.01%	1095

KBC Group's HPTX Position: Q2 2015 in Review

KBC Group sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 3,254 shares — an estimated $149K sold.

KBC Group first reported a position in HPTX in Q3 2013 and held it in 4 quarters. The position peaked at $149K in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

KBC Group reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
KBC Group sold 3,254 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $149K.
KBC Group first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q3 2013 and held it in 4 quarters.
KBC Group's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $149K in Q1 2015.
0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on KBC Group's 13F filing for Q2 2015, filed 31 Jul 2015.